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Here, we exploit the hair follicle to define the point
at which stem cells (SCs) become irreversibly com-
mitted along a differentiation lineage. Employing
histone and nucleotide double-pulse-chase and
lineage tracing, we show that the early SC descen-
dents en route to becoming transit-amplifying cells
retain stemness and slow-cycling properties and
home back to the bulge niche when hair growth
stops. These become the primary SCs for the next
hair cycle, whereas initial bulge SCs become
reserves for injury. Proliferating descendents further
en route irreversibly lose their stemness, although
they retain many SCmarkers and survive, unlike their
transit-amplifying progeny. Remarkably, these pro-
geny also home back to the bulge. Combining purifi-
cation and gene expression analysis with differential
ablation and functional experiments, we define crit-
ical functions for these non-SC niche residents and
unveil the intriguing concept that an irreversibly com-
mitted cell in an SC lineage can become an essential
contributor to the niche microenvironment.
INTRODUCTION
Adult stem cells (SCs) govern tissue homeostasis and wound
repair. They reside in a specific niche, defined as the microen-
viroment, that hosts and maintains SCs (Spradling et al., 2008).
Most SCs are infrequently cycling, a feature thought to preserve
their stemness, namely their ability to self-renew and remain
undifferentiated over the animal’s lifetime. During normal
homeostasis, they often exit from their niches and progress to
become transit-amplifying (TA) cells, undergoing a series of
rapid divisions before committing to terminal differentiation
(Fuchs, 2009; Morrison and Kimble, 2006).
Determining the point in a lineage hierarchy where SCs lose
long-term self-renewing capacity and become irreversibly
committed represents a fundamental and challenging question
in SC biology. Transitioning from a slow-cycling to more fast-
cycling state is not indicative, as hematopoietic stem cells
(HSCs) and hair follicle (HF) SCs can reversibly switch from
dormancy to cycling during normal homeostasis and wound92 Cell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc.repair (Blanpain et al., 2004; Foudi et al., 2009; Nowak et al.,
2008; Taylor et al., 2000; Waghmare et al., 2008; Wilson et al.,
2008). Merely exiting their niche is also not a reliable measure,
as some HSCs circulate, trafficking between their bone marrow
niche and extramedullary tissues (Cao et al., 2004). Even em-
barking along a differentiation pathway may not be an unequiv-
ocal indicator of loss of stemness; studies in Drosophila and
mouse testis show that germline SC niche vacancies can be
filled by early spermatogonial cells that dedifferentiate when
returned to the niche (Brawley and Matunis, 2004; Kai and Spra-
dling, 2004; Brinster and Avarbock, 1994).
Themurine HF offers an excellent system for monitoring an SC
lineage and exploring plasticity of SC progenies. During homeo-
stasis, the lower HF cycles through bouts of active hair growth
(anagen), destruction (catagen), and rest (telogen) (Lavker et al.,
2003; Paus and Cotsarelis, 1999). When the new HF emerges, it
grows next to the old hair, which persists into the next cycle.
This creates a protrusion or ‘‘bulge,’’ first described >100 years
ago (Unna, 1876). In 1990, nucleotide pulse-chase experiments
revealed the existence of slow-cycling, label-retaining cells
(LRCs) in the bulge (Cotsarelis et al., 1990). A decade later, these
cells were isolated, characterized, and shown to self-renew long-
term and contribute to HF lineages and wound repair (Blanpain
et al., 2004; Claudinot et al., 2005; Ito et al., 2005; Morris et al.,
2004; Tumbar et al., 2004; Zhang et al., 2009). These findings
established the bulge as a bona fide HF-SC niche.
Hair growth is fueled by bulge SCs, which are activated at the
start of anagen by the dermal papilla (DP), a cluster of underlying
mesenchymal cells. Upon activation, SCs exit the bulge and
proliferate downward, creating a long linear trail of cells, the
outer root sheath (ORS) (Ito et al., 2005; Zhang et al., 2009). In
mature HFs, the ORS extends from bulge to matrix. Enveloping
the DP at the HF base, matrix cells cycle rapidly but transiently
before differentiating upward to generate the hair and its channel
(Figure 1A and Figure S1A available online).
Catagen illuminates an unambiguous distinction between
long-lived HF-SCs and short-lived matrix progeny that undergo
massive apoptosis. The remaining epithelial strand retracts,
drawing the DP upward. Current evidence suggests that at the
catagen/telogen transition, a few bulge SCs migrate to meet
the DP, generating the hair germ (HG) (Ito et al., 2004; Zhang
et al., 2009). Bearing closer resemblance to bulge than matrix,
HG cells are activated prior to bulge at the start of anagen (Greco
et al., 2009). Prior to activation, HF-SCs undergo an extended
rest period that can last for months.
Figure 1. Dynamics of Slow- and Fast-Cycling
Cells throughout the Hair Cycle
(A) Cycling portions of amature HF. (B–D) Tet-Off H2BGFP
mice were chased from P21 to the days/stages noted
(P35–P37 corresponds to AnaVI). Before harvesting skin,
some mice were given 236 hr pulses of BrdU. Schematic
depicts H2BGFP cells (green) that will be label-retaining
(LRCs) when the chase is stopped at each stage. Cell #s
are counting down from the bulge base (= 0). In (C), the
right panels of each pair are duplicates of GFP mono-
chromes of the left panels. Scale bars, 30 mm. Bu, bulge.
DAPI in blue. In (D), note that S phase cells in AnaVI are
mainly in ORSlow and matrix. %HFs with BrdU+ cells in
bulge or in different ORS segments were quantified from
P29–P35. For each stage, n = 2mice andR23 HFs/mouse
were counted. Data are mean ± standard deviation SD.Whereas extensive studies have been performed on bulge
SCs and TA-matrix cells, the properties and fates of ORS cells
are less clear. Although these cells do not express high levels
of CD34, a marker of their SC bulge predecessors, they display
many HF-SC markers not found in matrix, including Lgr5, Sox9,
Lhx2, and TCF3 (Fuchs, 2009). To date, functional studies on
ORS cells have been limited to cultures of microdissected rat
whisker HFs, where long-term clones capable of engraftment
were obtained not only from bulge and ORS but also frommatrix
(Claudinot et al., 2005; Oshima et al., 2001; Rochat et al., 1994).
Whether ORS cells in vivo possess stemness like their predeces-
sors or are committed like their TA progeny remains unknown.
The unique regenerative aspects of HF homeostasis and the
transient, but spatially and temporally well-defined ORS offer
an unparalleled opportunity to examine the transition between
a SC and a TA cell. Where does the transition from slow cycling
to fast cycling occur along the ORS trail? What happens to ORS
cells during catagen? Do they undergo apoptosis like TA cells, or
do they survive like SCs? If they survive, do they home back to
the bulge, and if they do so, do they function as SCs?
Answering these questions could provide fundamental
insights into defining not only the importance of bulge to SC
survival but also the point where an SC loses its stemness and
embarks upon a terminal differentiation pathway. If all ORS cells
either die or differentiate during catagen, this would imply that
HF-SCs lose stemness once they leave the bulge. If on the other
hand, some ORS cells survive and return back to the bulge as
functional SCs, this would imply that at least at some point along
the progression from bulge to TA compartments, an SC that has
left the bulge still possesses intrinsic features of stemness.
In this report, we address these key questions in the unper-
turbed in vivo confines of the normal hair cycle, as well as in
response to injury. In so doing, we unearth surprising and
dynamic features of the HF-SC niche and its progeny. First, weCell 144show that during anagen, the upper ORS cells
remain slow cycling, like their SC predecessors,
whereas lower ORS cells cycle more rapidly.
Moreover, slow-cycling ORS cells survive cata-
gen and contribute mightily to both HG and
a new bulge: in fact, they become the main
source of SCs used during the next hair cycle.Lacking a DP, the initial bulge ceases to play a major role in
homeostasis but can respond to injury. Finally and perhaps
most surprisingly, some actively cycling lower ORS cells not
only survive catagen but also home back to the bulge. Like their
upper ORS predecessors, these cells retain many HF-SC
markers. However, they irreversibly lose their ability to proliferate
in normal homeostasis or upon wounding. Instead, they function
decisively in hair anchorage during the resting phase and in
providing the quiescent signaling cues that control the hair cycle.
Our findings define a point along the ORS where cells lose stem-
ness and become irreversibly fated to differentiate or die and
illuminate how downstream SC progeny can provide negative
feedback to the niche and restrict SC self-renewal and tissue
formation.
RESULTS
Bulge Descendents in Anagen ORS Can Be Subdivided
into Slow Cycling and Faster Cycling
To dissect the properties of bulge SC descendents along the
ORS,we first addressedwhether these cells remain slow-cycling
like bulge or become faster-cycling likematrix.We used bi-trans-
genic mice expressing Doxycycline (Doxy)-repressible histone
H2BGFP controlled by a keratin 5 (K5) promoter. With this Tet-
Off system, skin epithelium is uniformly labeled until Doxy expo-
sure, when new H2BGFP synthesis is tightly repressed and cells
deplete existing GFP by 23/division (Tumbar et al., 2004).
Doxy chase was begun at postnatal day (P)21, just before the
start of the 1st hair cycle (Figure 1B). At the last stage of anagen
(AnaVI, based on Muller-Rover et al., 2001; P35–P37 in these
mice), the bulge but not matrix contained bright H2BGFP LRCs
(Figures 1C and 1D). Interestingly, an LRC trail extended from
the bulge base along the ORS. To quantify, we standardized
image acquisition for GFP intensities by setting the detector so, 92–105, January 7, 2011 ª2011 Elsevier Inc. 93
Figure 2. Label-Retaining HF-SC Descendents in
the ORS Are Spared from Apoptosis during Cata-
gen and Form a New Bulge and HG at Telogen
Tet-Off H2BGFP mice were chased from P21 to the HF
stages indicated. Prior to analysis, some mice were given
a 4 hr BrdU pulse.
(A) H2BGFP LRCs maintain the same distribution from
anagen VI to catagen’s end.
(B) BrdU labeling in early catagen (Cat-II) shows prolifer-
ation only in matrix and ORSlow and not ORSGFP+ or
ORSmid.
(C–E) TUNEL and CP3 immunolabeling in catagen VI–VIII
reveals cell death in the retracting epithelial strand (ES) but
rarely in LRCs.
(F) Fate of H2BGFP LRCs at catagen to 2nd telogen
transition. Like the old bulge, the emerging new bulge and
HG contain LRCs. Quantifications: n = 3mice; 42 total HFs
analyzed for bulge; 87 for HG.
(G) HF-SC bulge marker CD34 is upregulated in upper
ORSGFP+ beginning at catagen V. The shape of the future
new bulge and HG can already be distinguished at Cat VIII.
HFs are outlined by dotted white line. White dots mark
autofluorescent hair shafts.
Scale bars, 30 mm. Data are mean ± SD.that brightest bulge cells were maximal but not saturated in a 12
bit (= 4096 shades) image. Under this condition, bulge was
composed almost exclusively of cells with GFP intensities
>256 (GFPbright). Within the first 16 positions counting down
along the ORS trail in a planar section, >85% of cells were
GFP+ (intensity > 16) with the majority of GFPbright cells in #1–12.
By contrast, few ORS cells in sites 16–30 were GFP+, and below
#30, GFP was not detected (Figure 1C and Figure S1B).
To further probe proliferation heterogeneities during anagen,
we performed a series of short BrdU pulse experiments in Tet-
Off H2BGFP mice. When labelings were conducted at intervals
between P27 and P29, i.e., after HFs displayed an emerging
inner root sheath (IRS) and typical anagen shape, BrdU+ cells
were detected in bulge, ORS, and matrix. By P31, however,
most bulge cells had ceased proliferation. Although occasional
BrdU+ cells were still seen in ORS positions 1–16, proliferation
was mostly beneath this zone in ORS and matrix. By P33,
most BrdU+ ORS cells were below #30, and from P35–P37,
BrdU+ cells were largely restricted to matrix, with few labeled
ORS cells <#40 (Figure 1D and Figure S1C). The transition
between ORS and matrix was at #75–85.
To summarize: ORSGFP+(#1–16) behaved similarly to bulge,
displaying slow-cycling characteristics and returning to quies-
cence 2 days after bulge proliferation ceased; ORSmid94 Cell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc.(#17–40) remained proliferative 2 days after
ORSGFP+; and ORSlow cells (#40–80) and matrix
cycled continuously.
SCs that Exit the Bulge during the Growth
PhaseandRemainSlowCycling (ORSGFP+)
Are Spared From Apoptosis during
the Destructive Phase
Because ORSGFP+ cells divide only a few
times during anagen, we next wondered whathappens to these cells during the destructive phase. Throughout
catagen, the ORSGFP+ trail showed no signs of migration or
expansion (Figure 2A). Three possible lineage behaviors could
explain this result: (1) GFP+ ORS cells are static in catagen; (2)
the influx of bulge cells to ORSGFP+ is compensated by an efflux
of ORSGFP+ cells, proliferating and moving toward matrix; (3)
ORSGFP+ cells undergo apoptosis and bulge cells migrate down-
ward to replace them.
To distinguish between thesemodels, wemonitored apoptotic
and proliferative events during this period. Early catagen was
marked by dramatic reduction in matrix proliferation (Figure 2B).
Cells within bulge and ORS were mostly quiescent during cata-
gen. These data rule out model 2. Soon thereafter, cell death
was detected by DNA fragmentation (TUNEL) and activated cas-
pase 3 (CP3). Apoptosis began within matrix and expanded
upward into the retracting epithelial strand (Figure 2C). However,
even toward catagen’s end, only a fewORSGFP+ and bulge LRCs
scored positive for TUNEL or CP3, and ultrastructural analysis
suggested that these were likely healthy cells that had engulfed
apoptotic debris (Figure 2D and Figures S2A–S2D). These data
rule out model 3. Together, these differences revealed a striking
molecular boundary between the TUNEL/CP3-positive epithelial
strand and the apparently unscathed LRCs in bulge and ORS.
These data are consistent with model 1.
ORSGFP+ Cells Form a New Bulge and Hair Germ
at the End of Catagen
As most ORSGFP+ cells survive catagen, we next addressed
where they go. Near the end of catagen, the LRC trail was still
located below the initial bulge. When HFs were followed into tel-
ogen and DP adopted its characteristic position directly below
the HG, it became apparent that the ORSGFP+ trail had adopted
a form resembling the HG and a new bulge (Figure 2E).
Imaging and quantifications coupled with fluorescence-
activated cell sorting (FACS) analysis confirmed that 98% of
CD34+ cells within this new bulge and 80%–90% of those in
HG were GFP+ (Figure 2F and Figure S3C). Because in the Tet-
Off H2BGFP system, a GFP cell from an earlier time cannot
be the source for a GFP+ cell at a later point, this leaves only
ORSGFP+ and initial bulge as possible sources for this structure.
Given that from catagen to telogen, the initial bulge showed
no major change in size or cell number (Figure S2E), our collec-
tive evidence favored ORSGFP+ as the major source of both this
new bulge and HG. These results were surprising, however,
because anagen ORSGFP+ cells did not show strong immunos-
taining for either bulge marker CD34 or HG marker P-cadherin.
After first confirming that new bulge and HG express these
markers (Figure 2F), we traced the temporal roots of these differ-
ences. Toward catagen’s end, the first 8 cells in the ORSGFP+
zone acquired strong CD34 immunostaining, whereas the lower
part of ORSGFP+ remained CD34 but became P-cadherin-bright
(Figure 2G; data not shown).
To further monitor these events, we performed a lineage-
tracing experiment with Lgr5-EGFP-IRES-CreER/Rosa-stop-
LacZ-stop mice (Barker et al., 2007). At full anagen, Lgr5 was
expressed by both bulge and ORS; however, as ORS is >153
larger than bulge, we could preferentially mark ORS cells by
giving a low dose of tamoxifen (Figure 3A; Figures S3A and
S3B). Indeed when examined by thick sections (90 mm) at ana-
gen’s end, >70% of HFs had LacZ+ ORS cells, whereas only
4% had LacZ+ bulge cells. When traced into telogen, >20%
of HFs had LacZ+ cells in new bulge or HG, whereas HFs with
LacZ+ cells in the old bulge remained at 5%. These data add
to the evidence that ORSGFP+ is the main source for both new
bulge and HG.
Based upon our proliferation analyses of ORS during anagen,
we next began with pulse-chased Tet-Off H2BGFP mice
and superimposed a series of BrdU pulse-chases that allowed
us to differentiate old bulge and ORSGFP+ and selectively label
different ORS segments. As proliferation within the initial bulge
occurs during early anagen (P25–P29), we preferentially
labeled ORS by administering BrdU at P30–P32 (Figure 3B).
Moreover, because cells below ORSGFP+ cycle frequently, a
6 day chase at anagen’s end and into catagen (P38) restricted
most BrdU+ cells to the ORSGFP+ zone. When chased further
into telogen, these GFP/BrdU double+ cells were found in
new bulge and HG, thereby demonstrating that the ORSGFP+
of the prior cycle contributes substantially to the new bulge
and HG.
Finally, we used epifluorescence intensity analyses to esti-
mate the average number of divisions that GFP+ LRCs within
each compartment undergo during a hair cycle. Because cell
divisions are silenced during catagen and telogen, GFP intensi-ties within each compartment are retained, and thus, their inten-
sities in telogen serve as a guide to their origin nearing anagen’s
end. Analyses of GFP+ cells chased from the start of the first
postnatal anagen to telogen revealed that cells that maintained
their residence in the initial bulge divided the least (23) during
the hair cycle: their epifluorescence corresponded to the old
bulge (Figure 3C). By contrast, cells that resided in the ORS
and acquired CD34 during catagen corresponded in epifluores-
cence to new bulge and on average divided 1–23more than the
old bulge. LRCs that resided in the ORS, but remained CD34,
displayed epifluorescence corresponding to HG and reflective
of 1–23 more divisions than new bulge. Quantifications in
control mice showed that without Doxy, HG and new and old
bulges displayed uniform levels of the highest H2BGFP signal,
underscoring tight Tet-Off regulation and validating the efficacy
of the data (Figure S3C).
Together, these results establish that cells in ORSGFP+ are the
major source of HG and new bulge. Furthermore, they unveil
a hitherto unrecognized relation between HF-SCs that exit the
bulge during the growth phase and the new bulge and HG that
form during the destructive phase.
Some Mid-Zone ORS Cells Contribute to the HG
The ability of cells within the ORSGFP+ to survive catagen led us
to wonder whether more fast-cycling bulge progeny located in
the middle or lower ORS might also be spared and possibly be
the source of the 10%–20% of HG cells with very low GFP.
To test this hypothesis, we delayed our BrdU pulse to P34–
P36, a time when most bulge and ORSGFP+ cells had ceased
proliferation. Although ORSmid cells were proliferative at this
time, they became quiescent soon thereafter, as evidenced by
their label retention after a 4 day chase. These BrdU+ LRCs
were uniformly low for GFP and could be found in the HG
following a chase into telogen (Figure S3D). Thus although
most of the HG was comprised of ORSGFP+ cells, the mid-zone
was the source of HG cells undergoing the most divisions in
the prior hair cycle. This cut-off was further defined by delaying
the BrdU pulse so that cells below the mid-zone were preferen-
tially labeled: under these conditions, no BrdU+ cells were
detected in the HG (see below).
Together, these experiments delineate the ORSGFP+ zone as
the point at which an HF-SC can exit the initial bulge and still
be recycled to the CD34+ new bulge. The point at which HF-SCs
can be recycled to the HG extends to the mid-zone. Moreover,
these data reveal a strong inverse correlation between the
number of divisions progeny have undergone and whether they
are recycled to bulge versus HG.
A Potential Conundrum: The Return of Some
Fast-Cycling BulgeDescendents below theORSmid Zone
to the Niche
During our double-label pulse-chase studies, we noticed that
some chased BrdU+ cells started to show up in the new bulge
when BrdU was pulsed at P34–P36. Their number increased
dramatically when the BrdU pulse was delayed to P36–P38
(end of anagen) and then chased through catagen, suggestive
that these cells came from a position below the ORS mid-
zone (Figure 4A). Closer inspection revealed that in contrastCell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc. 95
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to ORSGFP+, these BrdU+ cells were restricted to the innermost
new bulge. Immunolabeling and FACS analysis showed that
the cells were CD34 and hence distinct from suprabasal
CD34+ bulge cells described previously (Blanpain et al., 2004).
Instead, these cells were positive for keratin 6 (K6) (Figure 4A;
Figures S4A–S4C).
K6 is also known to mark the terminally differentiated com-
panion layer, which is derived from matrix during anagen and
sandwiched between ORS and IRS (Figure S1A). The K6+ bulge
cells differed from companion layer by their expression of key
HF-SC transcription factors (Figure 4B). Ultrastructurally, K6+
bulge cells also more closely resembled CD34+ bulge SCs
than companion layer cells (Figures S4D–S4F). However, they
differed from bulge SCs in making unusual adhesive contacts
with the club hair and extensive desmosomal contacts with
their neighbors. Thus, the cells fated to enter the innermost layer
of the new bulge at the end of catagen were distinct from any of
the known HF residents.
The K6+ Bulge Layer Is Derived from Actively Cycling
Cells in the Lower ORS
A priori, the K6+ bulge layer could be a bona fide companion
layer, derived from matrix but displaying distinct molecular
features at different hair cycle stages. Alternatively, it could be
derived from actively cycling lower ORS cells, which face a bar-
rier to lineage progression when matrix apoptoses (catagen IV).
The latter possibility was intriguing given that the ORS expresses
many HF-SC markers that matrix and anagen companion layers
do not (Rendl et al., 2005) (Figure S5A).
To identify the source of K6+ bulge cells, we first revisited
our Lgr5-CreER/Rosa-LacZ lineage tracings, which labeled
cells in both upper and lower ORS, but not matrix when induced
near the end of anagen (Figure 3A). In telogen, LacZ+ cells
were present in both CD34+ and K6+ bulge layers (Figure 3A
and Figure S5B). Similar results were obtained when lineage
tracings were conducted with K14creER/Rosa26-LacZ mice
(Figure S5C). Together with the BrdU pulse results, these data
suggest that the K6+ bulge layer comes from lower ORS and
not matrix.
To further demonstrate that the lower ORS/matrix cell
step that occurs during anagen is bypassed in catagen, we
used K14-Tet-On/H2BGFP mice, which, upon Doxy, turn on
H2BGFP in ORS (Nguyen et al., 2006). When Doxy was given at
mid-anagen and HFs were examined at anagen’s end, H2BGFP
was nicely expressed in ORS (including its CD34+ bulge layer)Figure 3. ORSGFP+ LRCs Form the HG and CD34+ SCs of the New Bulg
Schematics summarize experiments and results.
(A) Lineage tracingwith Lgr5CreER/Rosa-LacZ tomonitor ORS cell fate. Tamoxife
ORS (both up and low) but not bulge or matrix. When chased to telogen, LacZ+ c
176 HFs. Quantifications were on 90 mm sections; images shown are 20 mm sec
(B) H2BGFP/BrdU double-label, double-pulse-chase experiment to monitor fate o
pulses during mid-anagen (P30–P32) preferentially labeled cells in the upper ORS
BrdU+ LRCs in their ORSGFP+ (arrowhead); BrdU+ LRCs were rare elsewhere (n =
were mainly in the new bulge or HG (n = 3 mice, 58 HFs). Scale bars, 30 mm. new
(C) Relative epifluorescence intensities of cells from different LRC populations o
Raw datasets are plotted to right of each box-and-whisker diagram: median, 25
95th percentile are whiskers; minimum and maximum measurements are x’s. As
mean ± SD.but not matrix or companion layer (Figure 4C). Given that
H2BGFP is stable and ORS cells don’t divide during catagen,
the fate of label could be monitored. Through catagen IV, bright
H2BGFP persisted only in ORS. At catagen V after the matrix
apoptosed, GFP+ cells appeared in the K6+ layer at the tip of
the retracting club hair (shown).
These cells survived catagen, remained K6+ and GFP+, ex-
pressed HF-SC/ORS markers, and wound up in the telogen
bulge (Figure 4C; Figures S5F and S5G). Moreover, because
when chased into telogen, K6+ cells of new bulge were GFP+
whereas those of old bulge were GFP, the GFP labeling re-
flected lineage fate mapping and not ectopic K14 promoter
activity (shown). We also confirmed this by inducing H2BGFP
in telogen and verifying absence of GFP+ cells in the K6+ bulge
layer (Figure 4C; Figure S5D). These results exclude both
matrix and anagen companion layer as possible precursors of
the K6+ bulge. Moreover, the catagen-imposed bypassing of
the ORS/matrix transition explains the dramatically different
biology between cells of the K6+ bulge (ORS-derived) and
companion layer (matrix-derived).
To specifically follow the fate and movement of ORSlow cells,
we combined a BrdU pulse-chase scheme (pulse at the end of
anagen) with this Tet-On H2BGFP strategy. ORSlow was the
only population with BrdU/H2BGFP double+ cells in every HF.
As expected, starting from catagen V, double+ cells appeared
in the K6+ layer around the newly formed club hair and retracted
upward with it as the new bulge formed. During catagen, a few
double+ cells also appeared in the epithelial strand and in the
external layer flanking newly formed K6+ cells (Figure 4C; Fig-
ure S5G). In sharp contrast to these layers, however, no TUNEL+
or CP3+ cells were detected in the ORS-derived K6+ layer (Fig-
ure S5E, 0/352 HF examined). Thus, although some ORSlow cells
survived catagen and wound up in new bulge, they took up resi-
dence in the K6+CD34 layer.
K6+ Bulge Cells Do Not Participate in Normal
Homeostasis
We next wondered whether niche environment might restore
HF-SC function to lower ORS-derived bulge cells, enabling them
to utilize the remaining proliferative capacity they possessed
prior to catagen. The importance of testing this possibility was
heightened when we discovered that the K6+ layer displayed
not only HF-SC markers Sox9, Lhx2, and TCF3, still expressed
by lower ORS, but also nuclear NFATc1, previously found only
in bulge SCs (Horsley et al., 2008) (Figure S6A).e
n was given in full-anagen. Three days later (AnaVI), most HFs had LacZ+ cells in
ells showed up mainly in new bulge (both CD34+ and K6+ layers). n = 2 mice,
tions (hematoxylin counterstain).
f upper ORSGFP cells. Tet-Off H2BGFP mice were chased from P21 and BrdU
GFP trail. When chased to the anagen/catagen transition (P38), many HFs had
3 mice, 42 HFs). When chased to telogen (P43), BrdU+/GFP+ cells (arrowhead)
Bu and K6+ Bu denote CD34+ and K6+ layers of new bulge.
f Tet-Off H2BGFP mice chased from the 1st telogen through one hair cycle.
th and 75th percentiles are denoted by notch, bottom and top boxes; 5th and
terisks indicate significant differences between datasets (**p < 0.01). Data are
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Figure 4. K6+ Bulge Cells Express HF-SC Markers and Are Derived
from Actively Cycling Lower ORS during Catagen
(A) H2BGFP/BrdU double-label, double pulse-chase scheme tomonitor fate of
cells below the mid-zone ORS. BrdU was administered to Tet-Off H2BGFP
mice at anagen’s end (P36–P38) and analyzed directly, or after chasing to
telogen. At P38, many lower ORS and matrix cells are BrdU+ (n = 2 mice,
38 HFs). When chased to P43, BrdU+ LRCs are restricted to the K6+ layer of the
new bulge (n = 4 mice, 129 HFs).
(B) K6+ bulge cells express key transcription factors characteristic of bulge
SCs and their ORS progeny.
(C) Lineage tracing with K14Tet-On/H2BGFP coupled with BrdU pulse-chase.
Doxy was administered to turn on H2BGFP in the entire ORS, but not K6+
companion layer or matrix, in late anagen. From catagen V through telogen,
H2BGFP is detected in K6+ cells at the tip of the newly formed club hair. This
layer retracts with the club hair during catagen and winds up in the new bulge
by telogen. Note that K6+ old bulge cells are not GFP+. If BrdU is given at
anagen’s end, BrdU+/H2BGFP+ cells are found in ORSlow. At catagen, double+
cells are in the K6+ layer, which by telogen has moved inside new bulge.
Scale bars, 30 mm. K6+ club = K6+ layer enclosing new club hair. new Bu and
K6+ Bu denote CD34+ and K6+ layers of new bulge (n = 2 mice; >23 HFs per
stage). Data are mean ± SD.We first addressed whether K6+ bulge cells proliferate in
the next hair cycle. To capture proliferation if it existed, we pulsed
with BrdU throughout the 2 day window of early anagen when
HF-SCs are most active. Under conditions where >60% of98 Cell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc.CD34+ bulge cells incorporated BrdU, no proliferation was
detected in K6+ bulge cells of >190 HFs examined (Figure 5A).
Although the K6+ bulge layer was quiescent, it was possible
that some of its cells might migrate to the CD34+ layer or ORS
andcontribute to thehair cycle.We ruled this outbyadministering
BrdUat the end of anagen and then chasing into telogen to selec-
tively label K6+ bulge cells (Figure 5B). When chased throughout
the following hair cycle, no migration of BrdU-labeled cells was
observed. In the next telogen, BrdU label remained within the
K6+ layer of what became the old bulge (Figure 5B; Figure S6B).
Our data infer that even though highly proliferative cells in an-
agen can wind up in the bulge, slow-cycling CD34+ cells are the
source of new HFs. To further substantiate this, we took Tet-Off
H2BGFPmice that were chased from P21 to the 2nd telogen, so
that H2BGFP labeled CD34+ old and new bulge and CD34
HG but not K6+ bulge cells or HF cells above the bulge (Fig-
ure 5C). When the 2nd adult anagen began, the emerging follicle
was composed of GFP+ cells. Even though proliferation rapidly
diluted out label, the fluorescence intensity was still higher
than all other HF compartments except CD34+ bulge and HG.
Thus although prior lineage tracings have shown contributions
of CD34+ bulge and HG cells to the new HF (Morris et al.,
2004; Zhang et al., 2009), these new data further suggest that
cells in the K6+ bulge layer, junctional zone, sebaceous gland,
and infundibulum do not contribute to normal HF homeostasis.
Based upon these data, CD34+ slow-cycling SCs appear to be
the sole source of SCs used for HF homeostasis.
CD34+ HF-SCs in Both Old and New Bulge Participate in
WoundRepair, whereas K6+ BulgeCells DoNot Respond
to Either Wounding or CD34+ Bulge Cell Ablation
The new HF always emerged from new and not old bulge,
leading us to wonder whether the old bulge functions in normal
homeostasis. Careful inspection revealed an occasional prolifer-
ative cell at the base of the old bulge, but only when BrdU was
pulsed at anagen III, i.e., the height of new bulge activity (Fig-
ure 6A). However, when quantified, this constituted <15% of
combined bulge activity, indicating that the CD34+ new bulge
is primarily responsible for fueling new HF downgrowth.
CD34+ bulge cells are known to contribute to wound repair
(Blanpain et al., 2004; Ito et al., 2005; Morris et al., 2004). Two
additional questions now surfaced: (1) As the old bulge still
contains CD34+ HF-SCs, does it contribute to wound repair,
and if so, does it do so equivalently with the new bulge? (2) While
refractile to normal homeostasis, do K6+ bulge cells participate
in wound repair?
To address these questions, we introduced punch wounds
during the extended 2nd telogen, administered BrdU, and then
examined the skin 2 days later (Figure 6B). BrdU+ cells were
found in the CD34+ outer layer of new bulge and its associated
HG. Proliferating CD34+ cells were also detected in old bulge.
Quantifications revealed similar contributions from the bulges,
but only from CD34+ and not K6+ cells.
Next, we tested responses under more extreme conditions:
HF-SC ablation (Figure 6C). K15-CrePGR mice were used to
induce expression of diphtheria toxin receptors (DTRs) (Buch
et al., 2005) in CD34+ bulge cells. RU486 was given to activate
CrePGR, followed by DT to ablate CD34+ bulge cells. Activated
Figure 5. CD34+ Bulge SCs and HG Are the Only Cells Used in Normal HF Homeostasis
(A) Representative example and quantifications of HFs in early anagen (AnaII–AnaIII) with 2 day BrdU pulse. Note BrdU in some CD34+ HF-SCs (arrowheads) but
not inner K6+ bulge cells. White dots denote autofluorescent club hair (n = 2 mice, 61 HFs for AnaII; n = 3 mice, 133 HFs for AnaIII).
(B) A 2 day BrdU pulse given at anagen’s end is followed through two hair cycles. Although not proliferative, K6+ bulge cells retain label from late anagen
predecessors. K6+/BrdU+ cells persist through the next hair cycle and become the K6 layer of old bulge.
(C) Lineage tracing using Tet-Off H2BGFP mice shows that the new HF comes from bulge LRCs. Chase was begun at 1st telogen; analysis began at end of 2nd
telogen when H2BGFP selectively labels old bulge, new bulge, and HG. Developing HFs are composed solely of H2BGFP+ cells. IF, infundibulum; JZ, junctional
zone; SG, sebaceous gland. Scale bars, 30 mm. Box-and-whisker plots measure H2BGFP epifluorescence intensity within different HF populations. Note paucity
of GFP intensity in IF, JZ, and K6+ bulge, revealing their lack of contribution to GFP+ newly forming HF.
**p < 0.01. Data are mean ± SD.CP3 was prevalent in CD34+ but not K6+ bulge layers, verifying
selective targeting. Death was equivalent for both new and old
bulges, and a 2 day BrdU pulse prior to analyses further revealed
proliferation in CD34+ bulge cells that had not been ablated (Fig-
ure 6C; data not shown). By contrast, K6+ bulge cells did not
respond even when the HF-SC reservoir was depleted.
K6+ Bulge Cells Fail to Grow In Vitro
To address K6+ bulge cell potential, we devised a strategy to
isolate them by FACS and then carried out colony formation
assays (Figure 6D). An Lhx2-GFP transgene behaved similarly
to endogenous Lhx2, displaying GFP in both K6+ and CD34+
bulge layers of telogen HFs (Figure S6C). K6+ and CD34+ cells
in the GFP+ pool were then further fractionated by differential
CD34, E-cadherin, and integrin levels: K6+ bulge cells were
gated as GFP+CD34a6-b1Ecadhigh, whereas CD34+ cells
were sorted as GFP+ and CD34+. Post-sort marker analysis re-vealed >94% purity, and consistent with immunofluorescence,
RT-PCR showed that K6+ and CD34+ cells expressed similar
levels of Sox9, Lhx2, Tcf3, and Nfatc1 (Figures S6C and S6D).
In vitro, even though both populations attached to their sub-
stratum, only CD34+ and not K6+ bulge cells formed colonies
(Figure 6D). Collectively, these data suggest that lower ORS cells
that home back to the bulge have irreversibly lost their prolifera-
tive and regenerative potential.
K6+ Bulge Cells Function to Retain the Hair Coat
and Maintain HF-SC Quiescence
If K6+ bulge cells do not function as HF-SCs, what are their func-
tions in the bulge niche? The first clues came from hair-plucking
studies (Figure S7A). When telogen hairs were plucked, the
entire K6 layer came with the club hair, demonstrating a tight
association. By contrast, most CD34+ cells remained in the
bulge.Cell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc. 99
Figure 6. CD34+ but Not K6+ Bulge Cells Are Activated in Wound Repair and upon HF-SC Ablation
(A) Homeostasis. Mice given a 2 day pulse with BrdU at start of 2nd anagen were monitored to AnaIII. Arrowhead marks BrdU+ cell in old bulge, which is >33 less
active than new bulge (n = 3 mice, 62 HFs).
(B) Wounding. Punch biopsies were from 2nd telogen. BrdU given over 2 days shows that old and new bulges participate comparably in injury responses
(n = 3 mice, 31 HFs).
(C) SC ablation.K15-CrePGRwas used to express DTR in CD34+ bulge during 2nd telogen. After DT and BrdU,mice were analyzed (n = 3mice, 64 HFs). Note that
when bulge SCs are ablated, remaining CD34+ cells from old and new bulges proliferate, whereas K6+ bulge cells are refractory. Scale bars, 30 mm.
(D) K6+ and CD34+ bulge cells were isolated by FACS from telogen HFs of Lhx2-EGFP mice and subjected to culture experiments, performed in triplicate.
One thousand cells of each population were assayed for attachment 16 hr post-plating. K6+ andCD34+ cells were also plated, and at 3 weeks, colonieswere fixed
and stained with 1% Rhodamine B.
Data are mean ± SD.To test whether the K6+ layer functions to anchor the club hair
to the bulge, we devised a strategy to preferentially ablate K6+
versus CD34+ bulge cells (Figure 7A). Sox9-CreER (Soeda
et al., 2010) is expressed in both K6+ and CD34+ bulge layers.
However, in Sox9-CreER/Rosa-iDTRmice, when hairs were first
trimmed and tamoxifen was applied topically, drug entered
the hair pores and preferentially induced DTR in K6+ cells. By
contrast, RU486 induced DTR in CD34+ bulge cells of K15-
CrePGR/Rosa-iDTR mice (Figure 7D and data not shown).
Following DTR induction, mice were then treated with DT. Within
4 days, Sox9-iDTRmice began to show hair loss and by day (D) 6100 Cell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc.the coat was gone (Figure 7B; 5 of 5 mice tested). During this
time, K15-iDTR mice kept their hair coat even when slightly
more bulge cells were ablated (Figure S7B).
Interestingly, 2 days after hair loss, skins of Sox9-iDTR
mice became dark (Figure 7B). This indicator of anagen entry
(Muller-Rover et al., 2001) was substantiated by histological
analyses (shown). It occurred R50 days earlier than in K15-
iDTR or control mice (Figure 7C). By mechanisms unknown,
hair plucking also triggers anagen reentry. Interestingly, Sox9-
iDTR mice were >4 days quicker to enter anagen compared
to mice undergoing hair plucking, but K6+ bulge cells were
also lost by plucking (Figure S7A). These collective findings led
us to consider the possibility that it is loss of K6+ bulge that trig-
gers this precocious anagen. We therefore assessed whether
K6+ bulge cells actively participate in maintaining telogen.
To focus specifically on the effects of K6+ cell loss rather than
hair loss or mechanical trauma, we identified conditions wherein
sufficient K6+ bulge cells survived in our Sox9-iDTRmice so that
club hairs were retained longer. We then adjusted RU486 so that
total bulge cell death events were similar between Sox9- and
K15-iDTRmice (Figure S7B). Under these conditions, CP3+ cells
were detected in CD34+ (K15-iDTR) and K6+ (Sox9-iDTR) layers
beginning at D2, peaking at D4–D6 and waning by D10 (Fig-
ure 7D; data not shown).
In K15-iDTRmice, apoptosis was accompanied by brief prolif-
eration from surviving CD34+ bulge cells, as detected by
sequential BrdU pulses over this interval. This appeared to be
a repair response, as HFs thereafter returned to quiescence
and anagen was not induced (Figure 7E; Figure S7C). By
contrast, despite club hair retention (Figure 7E, inset), Sox9-
iDTR HFs not only displayed more robust CD34+ proliferation
but soon afterwards entered anagen. Throughout these treat-
ments, K6+ cells showed no signs of proliferation. These effects
were not observed with RU486, tamoxifen, or DT alone (Fig-
ure 7C; data not shown), confirming that K6+ bulge cells
contribute markedly in maintaining the resting state of the hair
cycle. Intriguingly, the effects of K6+ cell loss were transient:
following anagen entry, CD34+ bulge cells gradually returned
to quiescence (data not shown).
To explore what potential signals from the K6+ bulge might
influence CD34+ cell behavior, we focused on Fgf18 and
Bmp6. These genes were previously shown to be upregulated
in CD34+ telogen bulge cells in vivo, and their encoded factors
inhibit HF-SC cycling in vitro (Blanpain et al., 2004; Greco
et al., 2009). Remarkably, purified K6+ bulge cells displayed
enormous enrichment of these genes compared to other
epidermal or dermal cells that might impact on bulge microenvi-
ronment. Moreover, fgf18 and bmp6 expression levels were
>253 in K6+ versus CD34+ bulge cells (Figure 7F).
To test whether these factors account for the ability of K6+
bulge cells to maintain CD34+ bulge quiescence, we ablated
the K6+ layer in Sox9-iDTR mice and injected these growth
factors intradermally using fluorescent beads as a guiding refer-
ence. In contrast to buffer and beads alone, each of these factors
potently suppressed CD34+ bulge activation upon ablation of
the K6+ layer (Figure 7G; Figure S7D).
DISCUSSION
Recycling SCs Caught in Transit from Their Niche
to The TA Compartment
In this study, we examined the fate of HF-SCs that departed from
their niche but had not yet reached the TA pool when the destruc-
tive phase began. In contrast to the prevailing view, we discov-
ered that many ORS cells in transit between bulge and matrix
survive the massive apoptosis that follows anagen. By using
H2BGFP as a sensitive and stable label for lineage tracing,
we not only tracked the fate of CD34+ HF-SCs but also distin-
guished descendents on the basis of cell divisions that occurafter departing the niche. By combining this powerful approach
with classical lineage tracing and nucleotide pulse-chase, we
discovered that descendents closest to the bulge and that
undergo the fewest cell divisions are recycled and contribute
to the long-term SC pool that fuels the subsequent hair cycle.
Bulge descendents a little further en route become activated
SCs of the HG (Greco et al., 2009). Fast-cycling ORS cells nearer
to matrix return to the bulge and function, but not as bona fide
SCs (Figure S7F).
Recycled SCs Make a New Niche
It was hitherto unrecognized that HF-SCs that depart their niche
in one cycle become CD34+ bulge SCs for the next cycle.
Our findings further imply that HF-SCs with fewer divisions are
set aside in reserve within the old bulge, whereas those under-
going more divisions are recycled into a new bulge for homeo-
stasis. In this regard, it is intriguing that in hematopoiesis, the
most quiescent HSCs participate in injury repair whereas less
quiescent ones are used in homeostasis (Foudi et al., 2009;
Wilson et al., 2008). It will be interesting in the future to probe
deeper into the impact of cell divisions on HF-SC stemness
and to explore how melanoblast and other SCs in the bulge
migrate and function in this dynamic niche environment.
The Origin of the HG
Twomajor theories propose how the HG originates: (1) the lateral
disc hypothesis posits that the HG comes from Shh+ cells within
matrix (Panteleyev et al., 2001); and (2) the bulge migration
hypothesis suggests that HG cells migrate from the bulge at
the catagen/telogen transition (Ito et al., 2004; Zhang et al.,
2009). Bothmodels are attractive, and althoughShh+matrix cells
are not the source of HF-SCs or HG (Greco et al., 2009), we show
that cells outside the bulge clearly survive the destructive phase,
as initially speculated (Panteleyev et al., 2001). Moreover, our
study extends the similarities between HG and bulge (Greco
et al., 2009; Ito et al., 2004; Zhang et al., 2009) even though
HG appears to be derived from ORS-SCs that exited the bulge
during the prior growth phase.
Our findings agree with prior studies emphasizing close
proximity to DP stimuli in explaining why HG is activated so
quickly at the start of a new cycle (Greco et al., 2009). However,
our new data suggest that this enhanced sensitivity may also
rely upon the intrinsic feature of having traveled further along
the lineage and divided 1–23 more than new bulge cells. More-
over, as the ORS mid-zone is at the nexus along the lineage at
which long-term self-renewing potential begins to wane, this
could explain why HG cells do not sustain stemness in vitro
(Greco et al., 2009).
Unexpected Origins and Properties of the K6+ Bulge:
Insights into Hair Cycle Control
Our findings suggest that when catagen is initiated and matrix
undergoes apoptosis, proliferative cells in the lower ORS are
short-circuited and return to the bulge. This finding helps to
resolve the paradox as to why there are fast-cycling cells from
anagen that return to the bulge (Jaks et al., 2008). Since these
cells do expressmany HF-SCmarkers, it is tempting to conclude
that they are SCs coming home to roost. However, our dataCell 144, 92–105, January 7, 2011 ª2011 Elsevier Inc. 101
Figure 7. K6+ Bulge Cells Anchor the Club Hair and Serve as a Signaling Center for the HF-SC Niche
(A) Scheme to differentially express DTR in K6+ and CD34+ bulge cells and selectively DT-ablate each layer during extended 2nd telogen. D1 = day 1 of DT
injection. Sox9-iDTRhigh was treated with Tamoxifen for 4 days while Sox9-iDTRlow was treated for 2 days (see text).
(B) In contrast to K15-iDTR mice, Sox9-iDTR mice lose their hair coat at D6 (anchoring function) and skin turns black at D8, reflective of precocious entry into
anagen and confirmed by histology.
(C) Quantifications of anagen entry (signaling function). Graph shows #days before HFs entered anagen III for various genotypes/treatments. Horizontal bars
denote median.
(D and E) DT-treated K15- and Sox9-iDTRmice were given a 1 day BrdU pulse at times indicated prior to immunodetection of apoptotic and proliferation markers
on skin sections. In D10 Sox9-iDTR image, K6 marks the anagen companion layer. Scale bars, 30 mm. Graphs quantify %bulges positive for CP3, BrdU, and
anagen. Box-and-whisker plots indicate #events per HF/bulge: mid-line, median; box, 25th to 75th percentiles; whiskers, minimum and maximum.
(F) Real-time PCR on FACS-isolated populations. Values are normalized to total skin (epidermis+dermis) mRNAs.Bmp4 is higher in dermis (derm) and a6+ cells as
previously reported (Plikus et al., 2008). Note high Fgf18 and Bmp6 expression in K6+ bulge cells.
(G) Sox9-iDTRmice were treated 3 days with DT and growth factors and then 1 day with BrdU before analysis of proliferation (>24 HFs/experiment in duplicate).
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clearly show that once catagen sets in, the proliferative potential
of these cells ceases and cannot be reactivated for either
homeostasis or wound repair.
Themost interesting facet of these surviving lower ORS cells is
that despite their failure to regain proliferative potential, they
perform essential non-SC functions in the bulge. We posit that
their special ability to sense the bulge niche and thereby halt
upward protrusion of hair from the skin surface could originate
from retention of HF-SC markers when normal lineage progres-
sion is bypassed. Additional environmental cues (Figure S7E)
along the lineage may endow them with differentiation features
that enable their anchorage to the hair shaft and protect the
animal against cyclical alopecia.
Perhaps even more remarkable is that lower ORS-derived
bulge cells act as a signaling center in the niche (Figure 7H).
FGF18 and BMP6were previously identified as autocrine factors
able to maintain bulge SC quiescence (Blanpain et al., 2004;
Greco et al., 2009). Our findings confirm these data but also
point to a paracrine loop that likely transmits a burst of these
key factors to bulge SCs at the catagen/telogen transition
when the K6+ layer forms. By imposing potent quiescence
signals to the niche, the K6 bulge layer counterbalances the
activating role provided by the DP at this time. In this way, the
K6 bulge layer establishes the need for prolonged crosstalk
between HF-SCs and DP to generate the blocking factors that
enable HF-SCs to overcome this threshold (Greco et al.,
2009). Moreover, at anagen, the DP moves away from the niche
toward the matrix but the K6 layer remains with the bulge,
thereby launching a regulatory switch between bulge SCs and
TA matrix. We posit that the smaller autocrine FGF18/BMP6
signals may further provide a means for HF-SCs along the upper
ORS to retain their slow-cycling status until the new bulge is
formed. Our studies now pave the way to test such hypotheses
in the future.Lessons Learned about Stem Cell Biology
By taking advantage of the distinct cycling properties of the HF
lineage, we designed unambiguous lineage-tracing experiments
to determine the sources and fates of HF-SCs and their descen-
dents throughout homeostasis. By superimposing a temporal
series of pulse-chase experiments, we adopted the principles
of a movie to monitor HF-SC movement during the hair cycle.
This strategy could be useful for many other SCs that display
proliferative differences with their progeny.
Although the system has its advantages, the timing of labeling
can determine whether the slow-cycling SCs retain the label
(e.g., Cotsarelis et al., 1990; Morris and Potten, 1999) or their
committed fast-cycling progeny do (e.g., Jaks et al., 2008). Our
studies also reveal an example of SC progeny that have become
irreversibly committed and yet that still express SC markers and
home back to their SC niche. These revelations may help to
resolve some controversies that have arisen from label-retaining(H) Model summarizes different outcomes of ablating K6+ versus CD34+ bulge
activated briefly but then return to quiescence. When K6+ cells are ablated, qu
threshold for anagen activation. The K6+ bulge layer also functions to anchor the
**p < 0.01. Data are mean ± SD.and conventional lineage-tracing experiments in this and other
SC systems.
Several other concepts derived from our study could have
broad implications for SC biology: First, our data show that
a downstream lineage of SCs can be a critical component of
the niche microenvironment and regulate the rate of SC divi-
sions. However, our data also illustrate the power of intrinsic
factors on stemness. As exemplified by the K6+ bulge layer
and in contrast to theDrosophila germline (Brawley andMatunis,
2004; Kai and Spradling, 2004), once cells lose these features,
regaining stemness is not assured by returning to an unper-
turbed niche, nor by depleting the niche of its SCs. Thus,
although the niche can markedly affect SC behavior, it may not
be sufficient to reset the stemness clock once SCs have passed
the point of no return in a lineage. Future studies will be valuable
in further defining the distinctions and the parallels among
different SCs and their niches.
EXPERIMENTAL PROCEDURES
Mice and Labeling Experiments
Lhx2-EGFP was generated by the GENSAT project (Heintz, 2004). See
Extended Experimental Procedures for all other strains used. Tet-Off and
Tet-On were activated by continuously feedingmice with Doxy (2 mg/kg) start-
ing at P21 or times specified. CreER was activated by intraperitoneal injection
(150 mg/g tamoxifen in corn oil) or topical application (10 mg/ml in ethanol) as
specified. CrePGR activation was by topical application of RU486 (1% in
ethanol). For 5-Bromo-20-deoxyuridine (BrdU) pulse-chase experiments,
mice were injected intraperitoneally (50 mg/g) (Sigma-Aldrich) and chased for
times specified. To test for rare proliferations, injections were supplemented
with dietary BrdU water (0.8 mg/ml).
Hair Cycle Timing
Subdivisions of the hair cycle into 6 anagen and 8 catagen stages were based
on Muller-Rover et al. (2001). Because hair cycles vary among strains and
sexes, stages instead of mouse ages were usually evaluated. For K5-tTA/
pTRE-H2BGFPK5-tTA (Tet-Off) mice, both are provided. Typically 3–4 mice
of matched sex were analyzed.
Wounding and Ablation
0.6 cmpunch biopsy woundswere created on backs of anesthetizedmice. For
ablation of bulge cells, K15-CrePGR or Sox9-CreER X Rosa-iDTR mice were
first treated topically to induce Cre, then injected intraperitoneally (i.p.) with
diphtheria toxin (200 ng DT/injection, Sigma) 13/day for 5 days.
Quantifications of H2BGFP Intensities
Different stages of Tet-Off H2BGFP HFs were costained for CD34 and imaged
by LSM510 laser-scanning confocal (same laser input and gain). Fluorescence
intensities were measured using MetaMorph 7 (Universal Imaging Corp.).
Cell divisionnumberswereestimatedbasedonH2BGFPepifluorescence inten-
sity (brightest cells assigned 0 divisions). To reflect cell proliferation histories,
native H2BGFP intensities were measured. The exception is Figure 5C where
signals were enhanced with GFP antibody and laser input and gain were
increasedasnecessary todetectweaklyfluorescentcells. Individualdatapoints
were plotted, and statistic analyses (Student’s t test) were performed using
OriginLab 7.5 or Prism 5 software. Box-and-whisker plots are used to describe
the entire population without assumptions on statistical distribution (Schober
et al., 2007).cells in telogen. When CD34+ cells are ablated, remaining HF-SCs become
iescent signals (FGF18, BMP6) from K6+ bulge are lost, greatly reducing the
club hair.
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